From

Institution

Field

Type

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers matching “IKZF1 deletion” 6

Sort: Relevance Cited Newest Oldest Fwci Patents ⇩ CSV

Not finding it? Sign in to also search OpenAlex live.

Dutch ALL11 Study: Improved Outcome for Acute Lymphoblastic Leukemia By Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for ETV6::RUNX1, Down Syndrome and Prednisone Poor Responders
2022 Blood article Medicine Acute Lymphoblastic Leukemia research

Rob Pieters, Hester A. de Groot‐Kruseman, Femke Verwer, Merian van Overveld, Edwin Sonneveld, Marta F. Fiocco, +10 more

2

citations
Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups
2023 Journal of Clinical Oncology article Medicine Acute Lymphoblastic Leukemia research Open access

Rob Pieters, Hester de Groot‐Kruseman, Marta F. Fiocco, Femke Verwer, Merian van Overveld, Edwin Sonneveld, +11 more

42

citations
Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study
2021 The Lancet Haematology article Medicine Acute Lymphoblastic Leukemia research Open access

Naomi Michels, Judith M. Boer, Amir Enshaei, Rosemary Sutton, Mats Marshall Heyman, Sabine Ebert, +14 more

19

citations
Minimal Residual Disease, Long-Term Outcome, and IKZF1 Deletions in Down Syndrome Acute Lymphoblastic Leukemia in a Matched Cohort Study
2021 SSRN Electronic Journal preprint Medicine Acute Lymphoblastic Leukemia research Open access

Naomi Michels, Judith M. Boer, Amir Enshaei, Rosemary Sutton, Mats Marshall Heyman, Sabine Ebert, +15 more

0

citations
Tyrosine kinase inhibitor resistance in de novo BCR::ABL1–positive BCP-ALL beyond kinase domain mutations
2024 Blood Advances article Medicine Chronic Myeloid Leukemia Treatments Open access

Inge van Outersterp, Judith M. Boer, Cesca van de Ven, Caitlin E. J. Reichert, Aurélie Boeree, Brian Kruisinga, +5 more

10

citations
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study
2020 The Lancet Haematology article Medicine Acute Lymphoblastic Leukemia research Open access

Monique L. den Boer, Gunnar Cario, Anthony V. Moorman, Judith M. Boer, Hester A. de Groot‐Kruseman, Marta F. Fiocco, +18 more

71

citations

6 results